Health Canada Approves Biocon's Denosumab Biosimilars for Osteoprosis, Cancer-Related Bone Conditons

Apr 21, 2026

Global biopharmaceutical company Biocon Limited on Tuesday said Health Canada has granted a Notice of Compliance for its biosimilar Bosaya and Vevzuo, both denosumab-based...

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India

Aug 27, 2021

Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI)...